Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: January 13, 2026
Non-Hormonal Vaginal Ring

The Better Ring

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Elle MD Biotechnologies
Active
Last updated: January 13, 2026
Non-Hormonal Electrospun Mesh MPT
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal - Other
  • Intended Duration: Short-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): University of Lagos
Active
Last updated: January 13, 2026
Daily Oral Ulipristal Acetate

ROC

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Oral
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): Contraceptive Clinical Trials Network, NICHD, HRA Pharma
Active
Last updated: January 13, 2026
Serine Protease Inhibitor

4-(2-Aminoethyl)Benzenesulfonyl Fluoride (AEBSF), KLK3 Inhibitors

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Washington State University
Active
Last updated: January 7, 2026
Wondaleaf Unisex Condom
  • User: Female/Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Barrier
  • Intended Duration: Pericoital
  • Development Stage: Single-Country Approval
  • Developer(s)/Researcher(s): MRU - University of Witwatersrand, Twin Catalyst Sdn Bhd
Active
Last updated: January 7, 2026
Venova Barrier Device
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Barrier
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Venova Technologies
Active
Last updated: January 7, 2026
Vas Deferens RISUG

Reversible Inhibition of Sperm Under Guidance (RISUG)

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Long-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Indian Council for Medical Research, Indian Institute of Technology, Kharagpur, University of Rajasthan
Active
Last updated: January 7, 2026
Tenofovir + Levonorgestrel Vaginal Ring
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): CONRAD
Active
Last updated: January 7, 2026
STK33 Inhibitors

CDD-2807

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Baylor College of Medicine, University of Minnesota
Active
Last updated: January 7, 2026
SMRT Inhibitors

MS-275, SNDX-275, Entinostat

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Salk Institute for Biological Studies, University of California, Berkeley, University of California, Irvine, Utrecht University, University of Sydney